Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

A controlled trial trial to improve care for seriously ill hospitalized patients: The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment (SUPPORT)

Article Abstract:

Greater physician contact with seriously ill patients does not appear to improve the quality of care these patients receive during their final days. A two-part trial involved observations of the treatment of seriously ill patients by their doctors, followed by a second phase in which another group of doctors was given more information about the likelihood of survival of their patients. In the second phase, a specially trained nurse communicated with patient, family and physician in order to ensure that the patients' wishes about resuscitation and certain types of life support were known in advance. In the first phase, only 47% of doctors were aware of their patients desire to avoid CPR, and 46% of do-not-resuscitate orders were written within two days of the patient's death. Patients spent an average of 10 days in intensive care, and for half of those that were conscious during their final days, family members said they were in at least moderate pain. None of the outcomes improved in the second phase, suggesting that broader, societal changes will need to take place before physicians recognize the need to improve their care of the seriously ill.

Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1995
Research, Informed consent (Medical law), Informed consent, Right to die, Critical care medicine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Initiating End-of-Life Discussions With Seriously Ill Patients: Addressing the "Elephant in the Room"

Article Abstract:

Tips for initiating end-of-life discussions with patients are provided, using the case history of an 81-year-old man with a lung disease called pulmonary fibrosis, type 2 diabetes, a history of stroke, and chronic kidney failure.

Author: Quill, Timothy E.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Delirium at the End of Life: Critical Issues in Clinical Practice and Research

Article Abstract:

The causes, diagnosis, and treatment of delirium in terminally ill patients is discussed. Delirium is often transient and reversible, but can occur at the end of life as an irreversible condition.

Author: Lawlor, Peter G., Fainsinger, Robin L., Bruera, Eduardo D.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
Care and treatment, Delirium

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Analysis, Physician and patient, Physician-patient relations, Terminal care
Similar abstracts:
  • Abstracts: Can nurses refuse to care for a patient? Should nurses have the right to opt out of ECT treatment? How nurses view emotional involvement with patients
  • Abstracts: A randomized controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000g or less at birth
  • Abstracts: Comparison of the cigarette brand preferences of adult and teenaged smokers - United States, 1989, and 10 US communities, 1988 and 1990
  • Abstracts: Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease
  • Abstracts: The latent nuclear antigen of kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.